613 Pharmacokinetics/pharmacodynamics (PK/PD) of GSK2256098, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Advanced Solid TumorsHui Gan, M.J. Millward, Sarah P. Blagden et al.|European Journal of Cancer|2012Cited by 3
Characterization of BI 6727, a novel Polo-like kinase inhibitor with a distinct pharmacokinetic profile and efficacy in a model of taxane-resistant colon cancerSarah P. Blagden, Johann S. de Bono, David Olmos et al.|European Journal of Cancer Supplements|2008Cited by 2